Baseline characteristics among treated HCV and HCV/HIV infected participants with recently acquired HCV infection and adherent to PEG-IFN therapy (n = 89).
- Jordan J. Feld (151379)
- Jason Grebely (124046)
- Gail V. Matthews (340690)
- Tanya Applegate (371526)
- Margaret Hellard (124059)
- Alana Sherker (487764)
- Vera Cherepanov (487765)
- Kathy Petoumenos (300180)
- Barbara Yeung (487766)
- John M. Kaldor (234317)
- Andrew R. Lloyd (207808)
- Gregory J. Dore (205555)
Publication date
November 2013
DOIAbstract
*<p>at baseline,</p>¥<p>denominator is total number of people reporting documented illness.</p><p>SD, standard deviation.</p
Add to ORKG